BR9916102A - Desenvolvimentos em ou relacionados com pós - Google Patents

Desenvolvimentos em ou relacionados com pós

Info

Publication number
BR9916102A
BR9916102A BR9916102-8A BR9916102A BR9916102A BR 9916102 A BR9916102 A BR 9916102A BR 9916102 A BR9916102 A BR 9916102A BR 9916102 A BR9916102 A BR 9916102A
Authority
BR
Brazil
Prior art keywords
amino acid
particles
developments
powders
gcm
Prior art date
Application number
BR9916102-8A
Other languages
English (en)
Inventor
David Ganderton
David Alexander Vodden Morton
Paul Lucas
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Publication of BR9916102A publication Critical patent/BR9916102A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glanulating (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)

Abstract

Patente de Invenção: <B>"DESENVOLVIMENTOS EM OU RELACIONADOS COM PóS"<D>. Partículas de um aminoácido tal como leucina podem ser formadas de um vapor de aminoácido, por exemplo por condensação de aerossol, ou por secagem por spray. As partículas de aminoácido têm uma densidade de carga de não mais do que 0,1 gcm^ -3^ ou têm um diâmetro aerodinâmico médio de massa de não mais do que 10<109>m ou são na forma de flocos tendo uma espessura de não mais do que 100 <109>m. Constatou-se que a inclusão das partículas de aminoácido em pó para uso em inaladores de pó seco melhora a fração respirável do material ativo no pó.
BR9916102-8A 1998-12-09 1999-12-09 Desenvolvimentos em ou relacionados com pós BR9916102A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827145.5A GB9827145D0 (en) 1998-12-09 1998-12-09 Improvements in or relating to powders
PCT/GB1999/004156 WO2000033811A2 (en) 1998-12-09 1999-12-09 Improvements in or relating to powders

Publications (1)

Publication Number Publication Date
BR9916102A true BR9916102A (pt) 2001-09-04

Family

ID=10843948

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916102-8A BR9916102A (pt) 1998-12-09 1999-12-09 Desenvolvimentos em ou relacionados com pós

Country Status (24)

Country Link
US (1) US6989155B1 (pt)
EP (1) EP1137399B1 (pt)
JP (1) JP4410942B2 (pt)
KR (1) KR20010101138A (pt)
CN (1) CN1334723A (pt)
AT (1) ATE240093T1 (pt)
AU (1) AU770461B2 (pt)
BR (1) BR9916102A (pt)
CA (1) CA2353448C (pt)
CZ (1) CZ20012043A3 (pt)
DE (1) DE69907951T2 (pt)
DK (1) DK1137399T3 (pt)
EA (1) EA004045B1 (pt)
ES (1) ES2198973T3 (pt)
GB (1) GB9827145D0 (pt)
HU (1) HUP0104513A3 (pt)
MX (1) MXPA01005584A (pt)
NO (1) NO20012825D0 (pt)
NZ (1) NZ511965A (pt)
PL (1) PL348831A1 (pt)
PT (1) PT1137399E (pt)
SK (1) SK284775B6 (pt)
TR (1) TR200101591T2 (pt)
WO (1) WO2000033811A2 (pt)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
DK2280021T3 (en) 1999-06-29 2016-05-02 Mannkind Corp Pharmaceutical formulations comprising insulin complexed to a diketopiperazine
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2001151673A (ja) * 1999-09-06 2001-06-05 Nikken Chem Co Ltd 吸入用粉末製剤の製造方法
US7744855B2 (en) * 2000-06-27 2010-06-29 Vectura Limited Method of making particles for use in a pharmaceutical composition
JP5698423B2 (ja) * 2000-06-27 2015-04-08 ベクトゥラ・リミテッド 医薬組成物で使用するための粒子の製造法
EP1337240B2 (en) † 2000-11-30 2014-09-24 Vectura Limited Method of making particles for use in a pharmaceutical composition
ES2334642T5 (es) * 2000-11-30 2016-03-07 Vectura Limited Partículas para usar en una composición farmacéutica
PT1920763E (pt) 2000-11-30 2014-06-25 Vectura Ltd Composições farmacêuticas para inalação
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
JP2005520847A (ja) * 2002-03-20 2005-07-14 アドバンスト インハレーション リサーチ，インコーポレイテッド 肺投与用ｈＧＨ（ヒト成長ホルモン）製剤
CA2478974C (en) * 2002-03-20 2014-12-16 Advanced Inhalation Research, Inc. Inhalable sustained therapeutic formulations
CA2479751C (en) 2002-03-20 2008-06-03 Trent Poole Inhalation apparatus
RU2364400C2 (ru) * 2003-04-14 2009-08-20 Вектура Лтд Фармацевтические композиции
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
BRPI0514263B8 (pt) 2004-08-20 2021-05-25 Mannkind Corp método para a síntese de bis-3,6-[4-aminobutil]-2,5-dicetopiperazina n-protegida
DK2314298T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Microparticles comprising diketopiperazinsalte for drug delivery
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
MX2007009656A (es) 2005-02-10 2007-11-07 Glaxo Group Ltd Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma.
WO2007019229A1 (en) * 2005-08-05 2007-02-15 3M Innovative Properties Company Compositions exhibiting improved flowability
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
GB0525254D0 (en) 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
BRPI0707991B8 (pt) * 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
DE102006030164A1 (de) * 2006-06-29 2008-01-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Pulver
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
US20090048155A1 (en) 2007-08-15 2009-02-19 Endacea, Inc. Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection
US8785396B2 (en) 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
US9522916B2 (en) 2007-12-21 2016-12-20 Constance Neely Wilson A1 adenosine receptor antagonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AU2009257311B2 (en) 2008-06-13 2014-12-04 Mannkind Corporation A dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
DK2300083T3 (da) 2008-06-20 2013-07-22 Mannkind Corp Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2400950T3 (pl) 2009-02-26 2019-12-31 Glaxo Group Limited Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2011094208A2 (en) 2010-01-26 2011-08-04 Endacea, Inc. Methods and pharmaceutical compositions for preventing and treating renal impairment
WO2012030645A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
WO2012044736A1 (en) 2010-09-29 2012-04-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
ES2732818T3 (es) * 2010-11-09 2019-11-26 Mannkind Corp Composición que comprende un agonista de receptores de serotonina y una dicetopiperazina para tratar migrañas
AU2015249177B2 (en) * 2010-11-09 2017-08-03 Mannkind Corporation Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
ES2625858T3 (es) 2011-04-01 2017-07-20 Mannkind Corporation Paquete de tipo blíster para cartuchos farmacéuticos
RU2448717C1 (ru) * 2011-04-20 2012-04-27 Закрытое акционерное общество Научно-производственное предприятие "Тринита" Способ получения антикоагулянтно-фибринолитического средства на основе гепарина
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
JP6018640B2 (ja) 2011-10-24 2016-11-02 マンカインド コーポレイション 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
ES2624294T3 (es) 2012-07-12 2017-07-13 Mannkind Corporation Sistemas de suministro de fármacos en polvo seco
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation
EP2970149B1 (en) 2013-03-15 2019-08-21 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
JP7057290B2 (ja) 2016-06-27 2022-04-19 アキリオン ファーマシューティカルズ，インコーポレーテッド 医学的障害を治療するためのキナゾリン及びインドール化合物
WO2018163085A1 (en) * 2017-03-07 2018-09-13 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US20190177588A1 (en) * 2017-12-12 2019-06-13 Xotramorphic LLC Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
CN110441198A (zh) * 2018-05-03 2019-11-12 人福普克药业（武汉）有限公司 一种检测尼达尼布软胶囊中尼达尼布粒径的方法
EP3841086A4 (en) 2018-08-20 2022-07-27 Achillion Pharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D
JP2022517466A (ja) 2018-10-16 2022-03-09 ジョージア ステイト ユニバーシティー リサーチ ファウンデーション インコーポレイテッド 医学的障害の治療のための一酸化炭素プロドラッグ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6136346A (en) 1995-04-14 2000-10-24 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ES2343124T3 (es) * 1999-10-29 2010-07-23 Novartis Ag Composiciones de polvo seco con dispersabilidad mejorada.

Also Published As

Publication number Publication date
PT1137399E (pt) 2003-09-30
HUP0104513A2 (hu) 2002-03-28
CA2353448C (en) 2010-02-23
US6989155B1 (en) 2006-01-24
CN1334723A (zh) 2002-02-06
EP1137399B1 (en) 2003-05-14
DK1137399T3 (da) 2003-08-18
NO20012825L (no) 2001-06-08
SK284775B6 (sk) 2005-11-03
JP4410942B2 (ja) 2010-02-10
CZ20012043A3 (cs) 2001-12-12
EA004045B1 (ru) 2003-12-25
DE69907951D1 (de) 2003-06-18
EP1137399A2 (en) 2001-10-04
WO2000033811A3 (en) 2000-10-12
WO2000033811A2 (en) 2000-06-15
TR200101591T2 (tr) 2001-11-21
DE69907951T2 (de) 2004-03-11
SK7772001A3 (en) 2001-12-03
AU770461B2 (en) 2004-02-19
ATE240093T1 (de) 2003-05-15
EA200100636A1 (ru) 2001-12-24
HUP0104513A3 (en) 2003-12-29
CA2353448A1 (en) 2000-06-15
KR20010101138A (ko) 2001-11-14
NZ511965A (en) 2003-09-26
JP2002531487A (ja) 2002-09-24
ES2198973T3 (es) 2004-02-01
MXPA01005584A (es) 2003-07-14
PL348831A1 (en) 2002-06-17
NO20012825D0 (no) 2001-06-08
GB9827145D0 (en) 1999-02-03
AU1577700A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
BR9916102A (pt) Desenvolvimentos em ou relacionados com pós
BR9917246A (pt) Composições farmacêuticas avançadas em pó para inalação
CY1110136T1 (el) Συνθεσεις ξηρης σκονης με βελτιωμενη διασπαρσιμοτητα
BR0012351A (pt) Pós consistindo de partìculas com uma superfìcie perfeitamente macia, para uso como veìculos para a preparação de misturas de inalação com medicamentos micronizados e o método para sua preparação
BG101858A (en) Powder carrier for usage in dry inhalers
DE50313403D1 (de) Pulverinhalator
EA200801767A1 (ru) Фармацевтическая композиция для аэрозольного распыления с двумя действующими веществами и по меньшей мере одним поверхностно-активным веществом
BR0112903A (pt) Pó eletrostático
HK1076244A1 (en) Composition containing a cationic polymer with a high charge density and a conditioning agent
ATE474555T1 (de) Aerosol-zusammensetzung
SE9700135D0 (sv) New formulation
BR9909407A (pt) Produtos pigmentares
MX9404762A (es) Composiciones para inhalacion y proceso para su preparacion.
BR0016879A (pt) Métodos para transferência de interleucina-2 por via pulmonar
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
BRPI0608791B8 (pt) cápsulas para inaladores, uso de uma composição de polímero e processo para a secagem de pós para inalação
IS5110A (is) Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur búdesóníð
BR9915154A (pt) Composição dentifrìcia e utilização de partìculas abrasivas.
PL355688A1 (en) Antistatic powder coating compositions and their use
DK1223972T3 (da) Suspension af et EPI-hNE protein, fremgangsmåde til fremstilling deraf, tør pulveraerosol fremstillet deraf, farmaceutiske præparater indeholdende denne suspension eller aerosol samt anvendelser af disse
ES2179700T3 (es) Procedimiento para el recubrimiento de una superficie con un agente deseparacion.
ES2149083B1 (es) Nueva formulacion para inhalacion.
TW200730170A (en) Micronised azodicarbonamide, and the preparation and use thereof
SI1186292T1 (en) Dry carotinoid powder with a mulit-core structure

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: VECTURA LIMITED (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060042098/RJ DE 27/03/2006.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI